These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 29250555)

  • 1. A Comparison of Screening Tools for the Early Detection of Peripheral Neuropathy in Adults with and without Type 2 Diabetes.
    Brown JJ; Pribesh SL; Baskette KG; Vinik AI; Colberg SR
    J Diabetes Res; 2017; 2017():1467213. PubMed ID: 29250555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of diabetic neuropathy using a point-of-care nerve conduction device shows significant associations with the LDIFLARE method and clinical neuropathy scoring.
    Sharma S; Vas PR; Rayman G
    J Diabetes Sci Technol; 2015 Jan; 9(1):123-31. PubMed ID: 25231114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole plantar nerve conduction study: A new tool for early diagnosis of peripheral diabetic neuropathy.
    Galiero R; Ricciardi D; Pafundi PC; Todisco V; Tedeschi G; Cirillo G; Sasso FC
    Diabetes Res Clin Pract; 2021 Jun; 176():108856. PubMed ID: 33965449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reliability and validity of a point-of-care sural nerve conduction device for identification of diabetic neuropathy.
    Lee JA; Halpern EM; Lovblom LE; Yeung E; Bril V; Perkins BA
    PLoS One; 2014; 9(1):e86515. PubMed ID: 24466129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of the four simple methods in the diagnosis of diabetic peripheral neuropathy].
    Jia WP; Shen Q; Bao YQ; Lu JX; Li M; Xiang KS
    Zhonghua Yi Xue Za Zhi; 2006 Oct; 86(38):2707-10. PubMed ID: 17199983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One-stop microvascular screening service: an effective model for the early detection of diabetic peripheral neuropathy and the high-risk foot.
    Binns-Hall O; Selvarajah D; Sanger D; Walker J; Scott A; Tesfaye S
    Diabet Med; 2018 Jul; 35(7):887-894. PubMed ID: 29608799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of sural nerve conduction studies in patients with impaired oral glucose tolerance test.
    Koçer A; Domaç FM; Boylu E; Us O; Tanridağ T
    Acta Neurol Scand; 2007 Dec; 116(6):399-405. PubMed ID: 17986099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of life and objective measures of diabetic neuropathy in a prospective placebo-controlled trial of ruboxistaurin and topiramate.
    Boyd A; Casselini C; Vinik E; Vinik A
    J Diabetes Sci Technol; 2011 May; 5(3):714-22. PubMed ID: 21722587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and Safety of the Combination of Superoxide Dismutase, Alpha Lipoic Acid, Vitamin B12, and Carnitine for 12 Months in Patients with Diabetic Neuropathy.
    Didangelos T; Karlafti E; Kotzakioulafi E; Kontoninas Z; Margaritidis C; Giannoulaki P; Kantartzis K
    Nutrients; 2020 Oct; 12(11):. PubMed ID: 33114210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical utility of dorsal sural nerve conduction studies in healthy and diabetic children.
    Turgut N; Karasalihoglu S; Kücükugurluoglu Y; Balci K; Ekuklu G; Tütüncüler F
    Clin Neurophysiol; 2004 Jun; 115(6):1452-6. PubMed ID: 15134714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetic Neuropathy Evaluated by a Novel Device: Sural Nerve Conduction Is Associated with Glycemic Control and Ankle-Brachial Pressure Index in Japanese Patients with Diabetes.
    Hamasaki H; Hamasaki Y
    Front Endocrinol (Lausanne); 2017; 8():203. PubMed ID: 28861044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 6-month, randomized, double-masked, placebo-controlled study evaluating the effects of the protein kinase C-beta inhibitor ruboxistaurin on skin microvascular blood flow and other measures of diabetic peripheral neuropathy.
    Casellini CM; Barlow PM; Rice AL; Casey M; Simmons K; Pittenger G; Bastyr EJ; Wolka AM; Vinik AI
    Diabetes Care; 2007 Apr; 30(4):896-902. PubMed ID: 17392551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The development and validation of the Norfolk QOL-DN, a new measure of patients' perception of the effects of diabetes and diabetic neuropathy.
    Vinik EJ; Hayes RP; Oglesby A; Bastyr E; Barlow P; Ford-Molvik SL; Vinik AI
    Diabetes Technol Ther; 2005 Jun; 7(3):497-508. PubMed ID: 15929681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sural sensory action potential identifies diabetic peripheral neuropathy responders to therapy.
    Vinik AI; Bril V; Litchy WJ; Price KL; Bastyr EJ;
    Muscle Nerve; 2005 Nov; 32(5):619-25. PubMed ID: 16116628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Difficulties in screening for peripheral neuropathies in children with diabetes.
    Hirschfeld G; von Glischinski M; Knop C; Wiesel T; Reinehr T; Aksu F; Blankenburg M; Hirsch J; Zernikow B
    Diabet Med; 2015 Jun; 32(6):786-9. PubMed ID: 25640325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medial plantar and dorsal sural nerve conduction studies increase the sensitivity in the detection of neuropathy in diabetic patients.
    Uluc K; Isak B; Borucu D; Temucin CM; Cetinkaya Y; Koytak PK; Tanridag T; Us O
    Clin Neurophysiol; 2008 Apr; 119(4):880-5. PubMed ID: 18291716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Automated Quantification of Neuropad Improves Its Diagnostic Ability in Patients with Diabetic Neuropathy.
    Ponirakis G; Fadavi H; Petropoulos IN; Azmi S; Ferdousi M; Dabbah MA; Kheyami A; Alam U; Asghar O; Marshall A; Tavakoli M; Al-Ahmar A; Javed S; Jeziorska M; Malik RA
    J Diabetes Res; 2015; 2015():847854. PubMed ID: 26064991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bilirubin is inversely related to diabetic peripheral neuropathy assessed by sural nerve conduction study.
    Abe K; Maeda Y; Matsuzaki C; Yokomizo H; Inoue T; Sonoda N; Ogawa Y; Inoguchi T
    J Diabetes Investig; 2021 Nov; 12(11):2028-2035. PubMed ID: 33949141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Correlation between vibratory detection threshold and conduction study of sural nerve in diabetic patients].
    Ohnishi A; Yamamoto T; Murai Y; Ikeda M; Sugimoto H; Miyoshi T
    J UOEH; 1989 Dec; 11(4):425-8. PubMed ID: 2609039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Close relationship between cardiovagal function and sural sensory nerve action potential in type 2 diabetes.
    Lai YR; Huang CC; Chiu WC; Liu RT; Tsai NW; Wang HC; Lin WC; Cheng BC; Su YJ; Su CM; Hsiao SY; Wang PW; Chen JF; Ko JY; Lu CH
    Clin Neurophysiol; 2019 Jul; 130(7):1160-1165. PubMed ID: 31102989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.